Daclatasvir dihydrochloride
CAS: 1009119-65-6
Ref. TM-T1786
1g | 238.00 € | ||
5mg | 41.00 € | ||
10mg | 50.00 € | ||
25mg | 60.00 € | ||
50mg | 70.00 € | ||
100mg | 80.00 € | ||
500mg | 167.00 € | ||
1ml*10 (DMSO) | 52.00 € |
Product Information
- BMS-790052 dihydrochloride
- Bms 790052-05
- Carbamic acid, N,N′-[[1,1′-biphenyl]-4,4′-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]bis-, C,C′-dimethyl ester, hydrochloride (1:2)
- Daclatasvir.2HCL
- Daklinza
- N,N'-[[1,1'-Biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]biscarbamic acid dimethyl ester hydrochloride
Daclatasvir dihydrochloride (BMS-790052 dihydrochloride) is an orally available antiviral agent that inhibits the NS5A region of the hepatitis C virus (HCV) and is used in combination with other oral antiviral agents to treat chronic hepatitis C. Elevations in serum enzyme levels during daclatasvir therapy are uncommon, and it has yet to be convincingly implicated in cases of clinically apparent liver injury with jaundice.
Chemical properties
Technical inquiry about: TM-T1786 Daclatasvir dihydrochloride
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.